www.fdanews.com/articles/81982-astra-earnings-jump-49-percent
ASTRA EARNINGS JUMP 49 PERCENT
October 27, 2005
AstraZeneca Plc (AZN.L: Quote, Profile, Research) proved its reputation for above-average growth with a 49 percent jump in third-quarter earnings per share on Thursday, driven by a tight control of costs. Sales, however, fell short of expectations, dampening enthusiasm for the stock. Europe's third biggest drug maker increased its full-year outlook for earnings to $2.85-2.95 a share, from more than $2.75 a share previously, as margins at the group continued to improve.